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The relationship between the degree of skin fibrosis by sonoelastography and the degree
of pulmonary involvement in scleroderma
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Background/aim: This study aimed to assess the relationship between skin fibrosis as determined by sonoelastography and the degree of
pulmonary involvement as determined by high-resolution computed tomography (HRCT) in patients with diffuse cutaneous systemic
sclerosis (dcSSc).
Materials and methods: This prospective study included 40 patients with dcSSc. All patients with HRCT scans underwent conventional
ultrasonography and sonoelastography to determine skin thickness and degree of fibrosis. The degree of fibrosis was classified
according to color-scale sonoelastography. The degree of pulmonary involvement was classified according to HRCT grading groups.
The relationship between skin fibrosis and pulmonary involvement was investigated.
Results: There was a statistically significant difference between HRCT grading groups according to the sonoelastographic color scale
(P < 0.001). Sonoelastographic color-scale groups showed a statistically significant difference in duration of disease (P = 0.013). No
significant difference was found between the sonoelastographic color-scale groups in age, sex, or skin thickness.
Conclusion: Sonoelastography is a useful and reliable tool for assessing skin involvement in dcSSc. We found a good correlation between
the degree of skin fibrosis as determined by sonoelastography and the degree of pulmonary involvement.
Key words: Pulmonary involvement, scleroderma, skin fibrosis, sonoelastography

1. Introduction
Scleroderma (SSc) is a chronic multisystem disease
characterized by vascular dysfunction, immune activation,
and tissue fibrosis (1). Patients exhibiting fibrosis distal to
the elbows and knees are included in the limited cutaneous
disease subset (2). An increased risk of pulmonary arterial
hypertension is recognized in this group (3,4). More
extensive skin fibrosis involving the proximal portion of
the limbs or the trunk is classified as diffuse cutaneous
scleroderma (dcSSc), and patients with dcSSc have an
increased risk of restrictive lung disease (3–5). Lung
involvement is currently the leading cause of morbidity
and mortality in SSc, with a prevalence ranging between
30% and 90% of patients (5,6). A relationship between skin
and internal organ involvement has been shown in some
studies (7,8). Sonoelastography is an emerging technology
of ultrasonic imaging of soft tissue strain and elasticity
aimed at providing information about the mechanical
properties of tissues, such as their hardness or stiffness.
This technique has been used in breast, thyroid, prostate,
* Correspondence: mbcildag@yahoo.com

pancreas, lymph nodes, testes, and liver imaging; recently
some studies have also used sonoelastography for the
assessment of scleroderma (9–12).
We aimed to evaluate the relationship between skin
fibrosis as determined by sonoelastography and the
degree of pulmonary involvement as determined by highresolution computed tomography (HRCT) in patients
with scleroderma.
2. Materials and methods
This cross-sectional observational study was approved
by the local ethics committee of the School of Medicine
of Adnan Menderes University. The study included
patients with dcSSc who were classified according to the
American College of Rheumatology criteria (13). Eligible
patients with dcSSc were those who underwent HRCT
for the determination of interstitial lung involvement
during the last month. Patients with a disease that could
cause interstitial lung involvement other than dcSSc
were excluded. Patients’ demographic and clinical data
including age, sex, and disease duration were recorded.
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Sonoelastography was performed using an Aplio 500
(Toshiba Medical System Corporation, Tokyo, Japan)
machine with a 15-MHz linear probe. The target site was
the volar aspect of the middle forearm. Sonoelastographic
evaluation started after a conventional ultrasound
examination, which was performed to identify the
interface between the epidermis, dermis, and subcutis.
Vertical thickness of the skin was assessed in a B-mode
two-dimensional longitudinal image using a setting for
superficial structures with a single focal zone set at the
interface between the skin and subcutaneous fat. A gel pad
was used to provide an acoustic interface and to prevent
local artifacts from interposition of air. Sonoelastography
examinations were performed by applying slight
compression to the region of interest with the ultrasound
probe. The pressures and speeds of the manual
compressions were adjusted to view the subcutaneous fat
tissue as a mix of red and green. Both the B-mode and the
elastographic images were displayed on the screen during
the sonoelastographic examinations. The elastograms
were obtained by superimposing the color-scale images
on the B-mode images. The elastographic images were
considered related to the degree of tissue elasticity in
accordance with a color scale varying from red to blue, in
which red corresponds to soft tissue, green corresponds to
intermediate tissue, and blue corresponds to hard tissue
(9). Patients were divided into groups according to the
color scale in sonoelastography: group 1 - red pattern;
group 2 - green pattern; and group 3 - blue pattern (9,12).
All patients underwent HRCT examinations using
a 128-detector, 160-slice computed tomography device
(Prime Aquilion, Toshiba Medical Systems, Otawara,
Japan). Scans were obtained at full inspiration from the
apex to the lung base with patients in the supine position.
Scanning parameters were as follows: 120 kV, 300 mAs,
acquisition time 0.8 s, slice thickness 1 mm with 0.6-mm
reconstructions, and the smallest possible field of view
(FOV) covering both lungs. The scans were viewed with
a window level of 600 Hounsfield units (HU) and a width
of 1600 HU. HRCT grading of the thorax included: 0 normal; I - ground-glass appearance more than reticular;
II - equal ground-glass and reticular areas; III - reticular
area more than ground-glass; and IV - diffuse honeycomb
lesions in the upper and central zones. Due to the low
number of patients in each subgroup, HRCT grade 0 was
considered as no pulmonary involvement, grades I and II
were considered the low-grade group, and grades III and
IV were considered the high-grade group (14).
2.1. Statistical analysis
All statistical analyses were performed using SPSS 18.0
(SPSS Inc., Chicago, IL, USA). The Mann-Whitney U
test was used to compare nonparametric continuous
variables in independent groups based on the color scale.
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Descriptive data were given as frequencies, percentages,
means, and standard deviations. P < 0.05 was considered
statistically significant.
3. Results
The study included 40 patients with dcSSc: 28 women
(70%) and 12 men (30%), with or without pulmonary
involvement. The study period lasted from January 2015
to September 2016. The mean age of the patients was 58.8
years (range: 40–70), and the mean duration of disease was
202 months (range: 36–328). There was smoking history
in three patients. Six patients had comorbid diseases such
as diabetes mellitus, hypertension, and coronary artery
diseases. All patients were receiving treatment according
to EULAR recommendations (15). According to the color
scale, there were no patients with the red pattern (group 1);
14 patients had the green pattern (group 2) and 26 patients
had the blue pattern (group 3). The mean skin thickness
for all patients was 1.5 ± 0.35 mm. Patients were further
subdivided according to their HRCT findings; 10 patients
(25%) were in the group with no pulmonary involvement;
16 patients (40%) were in the low-grade group and 14
patients (35%) were in the high-grade group. There was a
statistically significant difference between HRCT grading
groups according to the sonoelastographic color scale (P
< 0.001). A higher rate of the blue pattern was seen in the
high-grade pulmonary involvement group. There was also
a statistically significant difference in duration of disease
between the sonoelastographic color-scale groups (P =
0.013). There was no significant difference in age, sex, or
skin thickness between the sonoelastographic color-scale
groups (P = 0.16, P = 0.88, and P = 0.63, respectively). The
demographic features of patients and HRCT findings by
color pattern groups are shown in the Table.
4. Discussion
We believe that this is the first study to indicate a
relationship between the degree of pulmonary involvement
and skin involvement as detected by sonoelastography
in patients with dcSSc. We also found that color-scale
patterns determined by sonoelastography are able to
distinguish the degree of pulmonary involvement as shown
by HRCT (Figures 1 and 2). In sonoelastography, the
blue pattern group indicating hardness showed excessive
pulmonary involvement. There was also a relationship
between the duration of disease and the color pattern in
sonoelastography.
In systemic sclerosis, skin involvement is a characteristic
manifestation. It can range from edema to fibrosis and
eventually to atrophy because of the excessive dermal
deposition of collagen and changes in the architecture
of the connective tissue (16). Several studies have shown
that the extent of skin involvement predicts internal organ
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Table. Demographic features and HRCT findings of patients by color pattern groups.

Sex (F)

Green pattern group,
mean ± SD n = 14

Blue pattern group,
mean ± SD n = 26

P -value

n = 10

n = 18

0.88

Age, years

57.71 ± 10.44

55.19 ± 9.35

0.16

Disease duration, months

56.93 ± 42.80

99.08 ± 58.87

0.013

Skin thickness (mm)

1.50 ± 0.27

1.52 ± 0.39

0.63

HRCT grading groups
No pulmonary involvement
Low-grade group
High-grade group

7
4
3

3
9
14

0.001

F: Female, n: number, HRCT: high-resolution computed tomography, SD: standard deviation. Statistically
significant values are given in bold font.

Figure 1. A 62-year-old female patient with dcSSc showed a green pattern on color-scale sonoelastography (A, B) and a normal
HRCT scan (C).

involvement and general outcome of patients (17,18). Skin
thickness assessment by palpation (modified Rodnan skin
score) is widely used in SSc, but it is a qualitative method and
has interobserver variability. High-frequency ultrasound
has been suggested for the determination of skin thickness
and echogenicity (16,19). However, it is not useful for
assessment of skin elasticity. Elastosonography allows for
the examination of the elastic properties of the skin with a
color scale superimposed on a gray-scale image produced
by conventional ultrasound (9–12). The principle behind
this technique is that the excessive dermal deposition of
collagenous and noncollagenous extracellular matrix
causing fibrosis reduces skin elasticity. Initial studies

carried out with elastosonography in systemic sclerosis,
such as that of Iagnocco et al. (9), indicated that dermal
stiffness is greater in patients with systemic sclerosis than
in controls. Specific color patterns of the dermis have been
identified in SSc patients compared to healthy subjects,
but several aspects need to be further confirmed and
studied. Cannaò et al. (12) described an elastographic
scale based on perioral segments and showed that perioral
stiffness is greater in patients with systemic sclerosis than
in controls. Hou et al. (20) used acoustic radiation force
elastosonography in SSc and defined this technique as
feasible and reliable for assessing skin involvement in
patients with dcSSc.
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Figure 2. A 58-year-old male patient with dcSSc showed a blue pattern on color-scale sonoelastography (A, B) and diffuse
honeycomb lesions in HRCT (C). He was included in the high-grade group of pulmonary involvement.

Interstitial lung disease (ILD) is a devastating and
significant cause of death in patients with SSc. In early
autopsy studies, up to 100% of patients were found to have
parenchymal involvement (6). HRCT has now become an
important part of the routine detection and evaluation of
SSc-ILD (21,22). It has been shown to be more accurate
than chest radiography in detecting and characterizing
diffuse lung diseases, and furthermore, abnormalities
on HRCT correlate more closely with physiologic
parameters (23). Although pulmonary involvement is
more common in dcSSc, no reliable association has been
found between pulmonary involvement and severity of
skin involvement (24). Cottrell et al. (25) showed that
the presence of pulmonary involvement was positively
associated with the pattern of skin involvement in 2205
patients with SSc. They used the modified Rodnan skin
score for the severity of skin involvement. In our study,
we investigated the relationship between the degree of skin
fibrosis as classified by sonoelastography and the degree
of pulmonary involvement. We showed that there was a

good correlation between skin fibrosis and the degree of
pulmonary involvement.
There are several limitations to our study. First,
we had a relatively small number of patients. Second,
there were no patients in the red pattern group. Third,
the semiquantitative sonoelastographic method was
operator-dependent. Fourth, the assessment of pulmonary
involvement was made only by HRCT, not by pulmonary
function tests. Further studies are needed to confirm our
findings and determine the validity of this new imaging
modality.
In summary, sonoelastography is a useful and
reliable tool for assessing skin involvement in dcSSc.
There was a good correlation between the degree of skin
fibrosis determined by sonoelastography and the degree
of pulmonary involvement. It seems that noninvasive
sonoelastographic assessment of the skin can give us an
idea about pulmonary involvement in patients with dcSSc.
Further studies with larger cohorts of patients are needed
to confirm the validity of sonoelastography for predicting
the severity of lung involvement in systemic sclerosis.
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